Evaluation and Management of a 15-Year-Old with Mild AST Elevation, Elevated Albumin, Total Protein, and Hypercalcemia
This adolescent requires immediate measurement of serum parathyroid hormone (PTH) to distinguish between PTH-dependent and PTH-independent causes of hypercalcemia, as this single test will direct all subsequent management. 1
Initial Diagnostic Approach
Confirm and Characterize the Hypercalcemia
Measure ionized calcium or calculate albumin-corrected calcium to confirm true hypercalcemia, as elevated albumin can falsely elevate total calcium measurements 2, 3. The corrected calcium formula is: Total calcium (mg/dL) + 0.8 [4 - Serum albumin (g/dL)] 4.
Obtain serum PTH level immediately as this is the most important initial test to evaluate hypercalcemia 1. An elevated or normal PTH indicates PTH-dependent causes (primary hyperparathyroidism), while suppressed PTH (<20 pg/mL) indicates PTH-independent causes 1.
Assess severity of hypercalcemia: Mild hypercalcemia is total calcium <12 mg/dL, while severe is ≥14 mg/dL 1. Severity determines urgency of intervention.
Additional Essential Laboratory Tests
Complete metabolic panel including serum creatinine, blood urea nitrogen, and phosphorus 4, 5.
25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels to evaluate for vitamin D-mediated hypercalcemia 4.
Alkaline phosphatase to assess for bone turnover abnormalities 4.
Complete blood count to screen for malignancy, as hypercalcemia can be the only presenting symptom of acute lymphoblastic leukemia in adolescents 6.
Urinary calcium-to-creatinine ratio on a random spot urine to assess for hypercalciuria 4.
Differential Diagnosis in Adolescents
PTH-Dependent Causes (Elevated/Normal PTH)
Primary hyperparathyroidism is the most common cause in adolescents with hypercalcemia and accounts for approximately 90% of cases along with malignancy 1, 7. In adolescents, this may present with neuropsychiatric symptoms including depression, anorexia, and self-harm behaviors 7.
Consider familial hypocalciuric hypercalcemia if there is family history and mild, asymptomatic hypercalcemia 5.
PTH-Independent Causes (Suppressed PTH)
Malignancy (lymphoma, leukemia) must be excluded, particularly if constitutional symptoms are present 6, 1.
Idiopathic infantile hypercalcemia can present in older children and adolescents 5.
Vitamin D intoxication from excessive supplementation 1.
Granulomatous disease (sarcoidosis) 1.
Medication-induced: thiazide diuretics, calcium or vitamin D supplements 1.
Evaluation of Liver Enzyme Abnormalities
Interpret AST Elevation in Context
Mild AST elevation (<5 times upper limit of normal) in an adolescent warrants evaluation for common causes including non-alcoholic fatty liver disease, viral hepatitis, autoimmune hepatitis, Wilson disease, and medication effects 4.
Obtain additional liver tests: ALT, alkaline phosphatase, gamma-glutamyl transferase (GGT), total and direct bilirubin, albumin, and prothrombin time/INR 4.
Use age- and sex-specific reference ranges for ALT (boys: 26 IU/L, girls: 22 IU/L as upper limits) 4.
Consider that hypercalcemia itself can cause gastrointestinal symptoms and may affect liver function 4, 5.
Common Pitfall to Avoid
Do not attribute elevated total protein and albumin to liver disease—these are typically decreased in hepatocellular dysfunction 4. Elevated albumin with hypercalcemia suggests the calcium elevation may be artifactually elevated or reflects a different underlying process 2, 3.
Imaging Studies
Renal ultrasonography to evaluate for nephrocalcinosis, which occurs in 45% of children with sustained hypercalcemia 4, 5.
Abdominal ultrasonography if liver disease evaluation is warranted based on persistent enzyme elevations 4.
Neck ultrasonography or sestamibi scan if primary hyperparathyroidism is confirmed, to localize parathyroid adenoma 7.
Management Based on Etiology and Severity
Asymptomatic Mild Hypercalcemia
Observation with close monitoring may be appropriate if calcium is <1 mg/dL above upper normal limit and no evidence of complications 1.
Ensure adequate hydration and avoid calcium and vitamin D supplements 4.
Monitor serum calcium every 4-6 months until etiology is established 4.
Symptomatic or Moderate-to-Severe Hypercalcemia
Initiate intravenous hydration with normal saline as first-line therapy 1.
Administer intravenous bisphosphonates (zoledronic acid or pamidronate) for symptomatic or severe hypercalcemia 6, 1.
Glucocorticoids are indicated if hypercalcemia is due to excessive intestinal calcium absorption (vitamin D intoxication, granulomatous disorders, lymphoma) 1.
Definitive Treatment
Parathyroidectomy is curative for primary hyperparathyroidism and should be considered, especially in adolescents with complications (nephrocalcinosis, bone disease, neuropsychiatric symptoms) 4, 7. Surgery may improve quality of life and psychological function 7.
Treat underlying malignancy if identified as the cause 6.
Monitoring and Follow-Up
Serial calcium measurements every 3-6 months if observation is chosen 4.
Assess for complications: nephrocalcinosis, bone disease, renal function deterioration 4, 5.
Monitor liver enzymes every 3-6 months if persistently elevated; consider liver biopsy if abnormalities persist beyond 6 months with unclear etiology 4.
Growth parameters and developmental milestones should be tracked in adolescents 4.
Critical Clinical Pearls
Hypercalcemia in adolescents is often asymptomatic or presents with non-specific symptoms (fatigue, constipation, gastrointestinal complaints), leading to delayed diagnosis 1, 5. Approximately 30% of pediatric patients with hypercalcemia are completely asymptomatic 5.
Neuropsychiatric symptoms including depression, anorexia, and behavioral changes may be the primary manifestation of hypercalcemia in adolescents and should prompt calcium screening 7.
The median time to diagnosis of hypercalcemia in children is 45 days due to non-specific presentation 5, emphasizing the importance of maintaining high clinical suspicion.